Presant CA - Search Results

1

Association of intratumoral pharmacokinetics of fluorouracil with clinical response.

Presant CA, Wolf W, Waluch V, Wiseman C, Kennedy P, Blayney D, Brechner RR. Presant CA, et al. Lancet. 1994 May 14;343(8907):1184-7. doi: 10.1016/s0140-6736(94)92399-x. Lancet. 1994. PMID: 7909867

2

Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil (5-FU)? A Southwest Oncology Group study.

Presant CA, Jacobson J, Wolf W, Waluch V, Weitz IC, Macdonald JS; Southwest Oncology Group. Presant CA, et al. Invest New Drugs. 2002 Nov;20(4):369-76. doi: 10.1023/a:1020651311866. Invest New Drugs. 2002. PMID: 12448653 Clinical Trial.

3

Human tumor fluorouracil trapping: clinical correlations of in vivo 19F nuclear magnetic resonance spectroscopy pharmacokinetics.

Presant CA, Wolf W, Albright MJ, Servis KL, Ring R 3rd, Atkinson D, Ong RL, Wiseman C, King M, Blayney D, et al. Presant CA, et al. J Clin Oncol. 1990 Nov;8(11):1868-73. doi: 10.1200/JCO.1990.8.11.1868. J Clin Oncol. 1990. PMID: 2230874

4

Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma.

Presant CA, Scolaro M, Kennedy P, Blayney DW, Flanagan B, Lisak J, Presant J. Presant CA, et al. Among authors: presant j. Lancet. 1993 May 15;341(8855):1242-3. doi: 10.1016/0140-6736(93)91147-e. Lancet. 1993. PMID: 8098393 Clinical Trial.

5

Non-invasive 19F-NMRS of 5-fluorouracil in pharmacokinetics and pharmacodynamic studies.

Wolf W, Waluch V, Presant CA. Wolf W, et al. Among authors: presant ca. NMR Biomed. 1998 Nov;11(7):380-7. doi: 10.1002/(sici)1099-1492(1998110)11:7<380::aid-nbm517>3.0.co;2-q. NMR Biomed. 1998. PMID: 9859944

6

Enhancement of fluorouracil uptake in human colorectal and gastric cancers by interferon or by high-dose methotrexate: An in vivo human study using noninvasive (19)F-magnetic resonance spectroscopy.

Presant CA, Wolf W, Waluch V, Wiseman CL, Weitz I, Shani J. Presant CA, et al. J Clin Oncol. 2000 Jan;18(2):255-61. doi: 10.1200/JCO.2000.18.2.255. J Clin Oncol. 2000. PMID: 10637237 Clinical Trial.

7

19F-MRS studies of fluorinated drugs in humans.

Wolf W, Presant CA, Waluch V. Wolf W, et al. Among authors: presant ca. Adv Drug Deliv Rev. 2000 Mar 15;41(1):55-74. doi: 10.1016/s0169-409x(99)00056-3. Adv Drug Deliv Rev. 2000. PMID: 10699305 Review.

8

Clinical responses to intralymphatic whole-cell melanoma vaccine augmented by in vitro incubation with alpha-interferon.

Wiseman C, Presant C, Rao R, Smith J. Wiseman C, et al. Ann N Y Acad Sci. 1993 Aug 12;690:388-91. doi: 10.1111/j.1749-6632.1993.tb44040.x. Ann N Y Acad Sci. 1993. PMID: 8368765 No abstract available.

9

Preliminary report: imaging of Kaposi sarcoma and lymphoma in AIDS with indium-111-labelled liposomes.

Presant CA, Blayney D, Proffitt RT, Turner AF, Williams LE, Nadel HI, Kennedy P, Wiseman C, Gala K, Crossley RJ, et al. Presant CA, et al. Lancet. 1990 Jun 2;335(8701):1307-9. doi: 10.1016/0140-6736(90)91188-g. Lancet. 1990. PMID: 1971378

10

Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits.

Wolf W, Presant CA, Servis KL, el-Tahtawy A, Albright MJ, Barker PB, Ring R 3rd, Atkinson D, Ong R, King M, et al. Wolf W, et al. Among authors: presant ca. Proc Natl Acad Sci U S A. 1990 Jan;87(1):492-6. doi: 10.1073/pnas.87.1.492. Proc Natl Acad Sci U S A. 1990. PMID: 2296605 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters